The U.S. Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals (NASDAQ:VRTX) non-opioid drug Journavx for acute pain, marking a breakthrough in pain management. Unlike traditional ...

Reynolds is one of a number of travelers whose anxiety has spiked in the days since the crash. “It's just becoming too ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

Mayor Keith James delivered his State of the City address Thursday morning, where he discussed several initiatives the city is working on, including affordable housing and the police department.

At only 13, she has felt worthless. After all, Ella Marquette's health insurance company recently denied her private duty nursing services.

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...

More than a decade after exiting health insurance, Nationwide has agreed to acquire a fast-growing employer benefits business ...

Mayor Keith James delivered his State of the City address Thursday morning, where he discussed several initiatives the city ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a ...

Dwyane Wade recalled how a routine checkup turned into a life-changing cancer diagnosis that forced him to confront his own ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain.T ...